Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect
Phase 2 Dose-finding Studies with MCP and Modelling Techniques
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your Statistician | JCO Precision Oncology
View Image
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study - The
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial - The Lancet Gastroenterology & Hepatology
Phases of clinical research - Wikipedia
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 m
a.k.a. Phase I trials) Dose Finding Studies. Dose Finding Dose finding trials: broad class of early development trial designs whose purpose is to find. - ppt download
Adaptive design (medicine) - Wikipedia
Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
Sample Size Re-estimation Design in Phase II Dose Finding Study with Multiple Dose Groups: Frequentist and Bayesian Methods | DeepAI
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014) - Musuamba - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Sequential dose-escalation study design | Download Scientific Diagram
![PDF] A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7c7543416a247a5a34e98769da2d20a023a4651c/3-Figure1-1.png "PDF] A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes | Semantic Scholar")
PDF] A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes | Semantic Scholar
An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Trial Design
Clinical Trial Phases | MD Anderson Cancer Center
Approaches to Combining Phase II Proof-of-Concept and Dose-Finding Trials | SpringerLink
Dose-Finding Studies in Phase II: Introduction and Overview | 11 | Han
Phase 2 Dose-finding Studies with MCP and Modelling Techniques - YouTube
PHASE I/II CLINICAL TRIAL DESIGN AND DOSE FINDING (PART I)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults | Nature
PHASE I/II CLINICAL TRIAL DESIGN AND DOSE FINDING (PART I)
